← TrialMatch
HomeTrials

Evaluation of the Vivo Isar Stent System in Routine Clinical Practice

The rationale for this observatory is to evaluate clinical outcomes and collect data of the Polymer Free Sirolimus Eluting Coronary Stent System in Real World CAD Patients with follow-up at 12 months. All medications and procedures to be used/ performed in this observatory are commonly used/performed for clinical indic

Condition(s)Artery Coronary Stenosis
StatusRecruiting
Study typeObservational
SummaryThe rationale for this observatory is to evaluate clinical outcomes and collect data of the Polymer Free Sirolimus Eluting Coronary Stent System in Real World CAD Patients with follow-up at 12 months. All medications and procedures to be used/ performed in this observatory are commonly used/performed for clinical indications as part of standard of care and have well-defined safety profiles.
Who can participateInclusion Criteria: * ≥18 years old * Ability to provide signed informed consent form. * Male or non-pregnant female patient (Pregnancy status to be confirmed verbally from the female patient of reproductive age) * Presentation with acute coronary syndrome or chronic coronary syndrome with stable angina or angina equivalent symptoms or with a positive noninvasive test for ischemia or evidence of a functionally significant coronary stenosis. * Patient having social security number. * Patient treated only with Vivo ISAR stent in case of single or multiple vessel stenting Exclusion Criteria: * Concurrent participation in another clinical trial. * Having benefited from an angioplasty of ≤ 1 month with a stent other than Vivo ISAR. * Planned elective surgery in next 6 months * Cardiogenic shock
Ages18 Years
SexAll
Lead sponsorTranslumina GmbH
LocationsAix-en-Provence, France; Caen, France; Colmar, France; Essey-lès-Nancy, France; Haguenau, France; Marseille, France (+13 more sites)
Start date2023-11-29
NCT IDNCT06420505
Official listinghttps://clinicaltrials.gov/study/NCT06420505

🔍 Search all trials →